Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

Université Laval

$105,000.00

Genetics of the metabolic syndrome

EF 2008-09

Résumé
The increase in the proportion of people suffering of obesity has a significant impact on health care system due to high rates of heart disease, diabetes and certain types of cancer that are developing in obesity condition. While the risk of developing these chronic diseases is important in obese subjects, a significant proportion of obese individuals remain healthy. Our knowledge of the factors explaining this situation is incomplete, but there is strong evidence for genetic components. Since 2000, Dr. Marie-Claude Vohl's team analyses genes expressed in fat tissues of obese patients' who received an anti-obesity surgery at Laval Hospital in Quebec City. They discovered several genes that could be associated with the development of heart disease and diabetes in obese subjects. To date, Dr. Vohl's team reported in the scientific literature 2 genes (ZFP36 and CYR61) related with blood cholesterol levels, as well as blood sugar and insulin concentrations in obese subjects, which are important factors of obesity-related metabolic complications. In the next few years, many other genes need to be linked with factors enhancing the risk to suffer heart disease and diabetes in presence of obesity. We are expecting to have more than 1800 severely obese patients, which will represent the largest group of patients with severe obesity worldwide for which DNA, fat tissues and clinical values (blood analyses, body weight, lifestyle habits, etc.) will be available. Given its dramatic impact in our society, there is a need to define the genetic causes of obesity-related metabolic complications to better point out obese subjects that are more likely to develop heart disease and diabetes. This will help physicians to choose the appropriate intervention for each patient, which could be specific modifications of lifestyle habits and/or effective drug treatment.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
184667
Name
Turcot Valérie
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
Doctoral Research Awards - A
Projecttitle
Genetics of the metabolic syndrome
Programtype2
Studentship Programs
Orgnameinp2
Université Laval
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Cardiovascular Disease Risk Factors; Endocrine And Paracrine Signalling; Gene Expression; Haplotypes; Immune And Inflammatory Response; Lipid Metabolism; Metabolic Syndrome; Obesity; Single Nucleotide Polymorphisms; Transcription Factor
Abstract
The increase in the proportion of people suffering of obesity has a significant impact on health care system due to high rates of heart disease, diabetes and certain types of cancer that are developing in obesity condition. While the risk of developing these chronic diseases is important in obese subjects, a significant proportion of obese individuals remain healthy. Our knowledge of the factors explaining this situation is incomplete, but there is strong evidence for genetic components. Since 2000, Dr. Marie-Claude Vohl's team analyses genes expressed in fat tissues of obese patients' who received an anti-obesity surgery at Laval Hospital in Quebec City. They discovered several genes that could be associated with the development of heart disease and diabetes in obese subjects. To date, Dr. Vohl's team reported in the scientific literature 2 genes (ZFP36 and CYR61) related with blood cholesterol levels, as well as blood sugar and insulin concentrations in obese subjects, which are important factors of obesity-related metabolic complications. In the next few years, many other genes need to be linked with factors enhancing the risk to suffer heart disease and diabetes in presence of obesity. We are expecting to have more than 1800 severely obese patients, which will represent the largest group of patients with severe obesity worldwide for which DNA, fat tissues and clinical values (blood analyses, body weight, lifestyle habits, etc.) will be available. Given its dramatic impact in our society, there is a need to define the genetic causes of obesity-related metabolic complications to better point out obese subjects that are more likely to develop heart disease and diabetes. This will help physicians to choose the appropriate intervention for each patient, which could be specific modifications of lifestyle habits and/or effective drug treatment.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Turcot, Valérie
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~